Particle-size-dependent toxicity and immunogenic activity of mesoporous silica-based adjuvants for tumor immunotherapy

Acta Biomaterialia

Volumn 9, Issue 7, 2013, Pages 7480-7489

  Wang, Xiupeng ^a   Li, Xia ^a   Ito, Atsuo ^a   Sogo, Yu ^a   Ohno, Tadao ^b  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b WASEDA UNIVERSITY   (Japan)

Author keywords

Adjuvant; Cancer; Immune therapy; Mesoporous silica; Pathogen associated molecular patterns

Indexed keywords

APATITE; CELLS; CYTOTOXICITY; MESOPOROUS MATERIALS; PRECIPITATION (CHEMICAL); SILICA; TUMORS;

ADJUVANT; ANTITUMOR IMMUNITY; IMMUNE THERAPY; IN-VITRO; IN-VIVO; MESOPOROUS SILICAS; PARTICLES SIZES; PATHOGEN-ASSOCIATED MOLECULAR PATTERNS; VITRO AND IN VIVO; VITRO CYTOTOXICITIES;

PARTICLE SIZE;

ADJUVANT; ALUMINUM POTASSIUM SULFATE; APATITE; MS AP PAMP; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; FEMALE; IMMUNOGENICITY; IN VITRO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TOXICITY;

MUS;

EID: 84878274751     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2013.03.031     Document Type: Article

References (65)

1. J.N. Blattman, and P.D. Greenberg Cancer immunotherapy: a treatment for the masses Science 305 2004 200 205
2. S.G. Reed, S. Bertholet, R.N. Coler, and M. Friede New horizons in adjuvants for vaccine development Trends Immunol 30 2009 23 32
3. A. Pashine, N.M. Valiante, and J.B. Ulmer Targeting the innate immune response with improved vaccine adjuvants Nat Med 11 2005 S63 S68
4. D.T. O'Hagan, and E. De Gregorio The path to a successful vaccine adjuvant - 'the long and winding road' Drug Discov Today 14 2009 541 551
5. R.O. Dillman, C. DePriest, C. DeLeon, N.M. Barth, L.S. Schwartzberg, and L.D. Beutel Patient-specific vaccines derived from autologous tumor cell lines as active specific immunotherapy: results of exploratory phase I/II trials in patients with metastatic melanoma Cancer Biother Radiopharm 22 2007 309 321
6. M.G. Hanna Jr., H.C. Hoover Jr., H.M. Pinedo, and M. Finer Active specific immunotherapy with autologous tumor cell vaccines for stage II colon cancer: logistics, efficacy, safety and immunological pharmacodynamics Hum Vaccin 2 2006 185 191
7. M. Kuang, S.Q. Liu, K. Saijo, E. Uchimura, L. Huang, and K.W. Leong Microwave tumour coagulation plus in situ treatment with cytokine- microparticles: induction of potent anti-residual tumour immunity Int J Hyperther 21 2005 247 257
8. S.Q. Liu, K. Saijo, T. Todoroki, and T. Ohno Induction of human autologous cytotoxic T lymphocytes on formalin-fixed and paraffin-embedded tumour sections Nat Med 1 1995 267 271
9. A. Wack, and R. Rappuoli Vaccinology at the beginning of the 21st century Curr Opin Immunol 17 2005 411 418
10. R.T. Kenney, and R. Edelman Survey of human-use adjuvants Expert Rev Vaccines 2 2003 167 188
11. L.P. Mercuri, L.V. Carvalho, F.A. Lima, C. Quayle, M.C.A. Fantini, and G.S. Tanaka Ordered mesoporous silica SBA-15: a new effective adjuvant to induce antibody response Small 2 2006 254 256
12. P.P. Yang, S.L. Gai, and J. Lin Functionalized mesoporous silica materials for controlled drug delivery Chem Soc Rev 41 2012 3679 3698
13. T. Ukmar, M. Gaberscek, F. Merzel, and A. Godec Modus operandi of controlled release from mesoporous matrices: a theoretical perspective Phys Chem Chem Phys 13 2011 15311 15317
14. T. Ukmar, U. Maver, O. Planinsek, V. Kaucic, M. Gaberscek, and A. Godec Understanding controlled drug release from mesoporous silicates: theory and experiment J Control Release 155 2011 409 417
15. P. Sher, G. Ingavle, S. Ponrathnam, J.R. Benson, N.H. Li, and A.P. Pawar Novel/conceptual floating pulsatile system using high internal phase emulsion based porous material intended for chronotherapy AAPS PharmSciTech 10 2009 1368 1380
16. S.W. Song, K. Hidajat, and S. Kawi Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions Langmuir 21 2005 9568 9575
17. T. Ukmar, U. Maver, O. Planinsek, A. Pintar, V. Kaucic, and A. Godec Guest-host van der Waals interactions decisively affect the molecular transport in mesoporous media J Mater Chem 22 2012 1112 1120
18. N.Z. Knezevic, and V.S. Lin A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug Nanoscale 2013
19. Q. Zhang, F. Liu, K.T. Nguyen, X. Ma, X.J. Wang, and B.G. Xing Multifunctional mesoporous silica nanoparticles for cancer-targeted and controlled drug delivery Adv Funct Mater 22 2012 5144 5156
20. X. Li, L.X. Zhang, X.P. Dong, J. Liang, and J.L. Shi Preparation of mesoporous calcium doped silica spheres with narrow size dispersion and their drug loading and degradation behavior Microporous Mesoporous Materials 102 2007 151 158
21. M. Van Speybroeck, V. Barillaro, T. Do Thi, R. Mellaerts, J. Martens, and J. Van Humbeeck Ordered mesoporous silica material SBA-15 a broad-spectrum formulation platform for poorly soluble drugs J Pharm Sci-Us 98 2009 2648 2658
22. R. Mellaerts, M.B.J. Roeffaers, K. Houthoofd, M. Van Speybroeck, G. De Cremer, and J.A.G. Jammaer Molecular organization of hydrophobic molecules and co-adsorbed water in SBA-15 ordered mesoporous silica material Phys Chem Chem Phys 13 2011 2706 2713
23. H. Vallhov, S. Gabrielsson, M. Strømme, A. Scheynius, and A.E. Garcia-Bennett Mesoporous silica particles induce size dependent effects on human dendritic cells Nano Lett 7 2007 3576 3582
24. N.L. Berinstein Enhancing cancer vaccines with immunomodulators Vaccine 25S 2007 B72 B88
25. X.P. Wang, X. Li, K. Onuma, A. Ito, Y. Sogo, and K. Kosuge Mesoporous bioactive glass coatings on stainless steel for enhanced cell activity, cytoskeletal organization and AsMg immobilization J Mater Chem 20 2010 6437 6445
26. X. Li, X.P. Wang, A. Ito, Y. Sogo, K. Cheng, and A. Oyane Effect of coprecipitation temperature on the properties and activity of fibroblast growth factor-2 apatite composite layer Mat Sci Eng C-Bio S 29 2009 216 221
27. X.P. Wang, A. Ito, Y. Sogo, X. Li, H. Tsurushima, and A. Oyane Ascorbate-apatite composite and ascorbate-FGF-2-apatite composite layers formed on external fixation rods and their effects on cell activity in vitro Acta Biomater 5 2009 2647 2656
28. H. Autefage, F. Briand-Mesange, S. Cazalbou, C. Drouet, D. Fourmy, and S. Goncalves Adsorption and release of BMP-2 on nanocrystalline apatite-coated and uncoated hydroxyapatite/beta-tricalcium phosphate porous ceramics J Biomed Mater Res B Appl Biomater 91 2009 706 715
29. D.R. Ciocca, P. Frayssinet, and F.D. Cuello-Carrion A pilot study with a therapeutic vaccine based on hydroxyapatite ceramic particles and selfmantigens in cancer patients Cell Stress Chaperon 12 2007 33 43
30. X. Li, X.P. Wang, Y. Sogo, T. Ohno, K. Onuma, and A. Ito Mesoporous silica-calcium phosphate-tuberculin purified protein derivative composites as an effective adjuvant for cancer immunotherapy Adv Healthcare Mater 2013 10.1002/adhm.201200149
31. M.O. Oyewumi, A. Kumar, and Z.R. Cui Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses Expert Rev Vaccines 9 2010 1095 1107
32. X.R. Li, B.R. Sloat, N. Yanasarn, and Z.R. Cui Relationship between the size of nanoparticles and their adjuvant activity: data from a study with an improved experimental design Eur J Pharm Biopharm 78 2011 107 116
33. T. Fifis, A. Gamvrellis, B. Crimeen-Irwin, G.A. Pietersz, J. Li, and P.L. Mottram Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors J Immunol 173 2004 3148 3154
34. I. Gutierro, R.M. Hernandez, M. Igartua, A.R. Gascon, and J.L. Pedraz Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres Vaccine 21 2002 67 77
35. J. Panyam, and V. Labhasetwar Dynamics of endocytosis and exocytosis of poly(d, l-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells Pharmaceut Res 20 2003 212 220
36. S.D. Xiang, A. Scholzen, G. Minigo, C. David, V. Apostolopoulos, and P.L. Mottram Pathogen recognition and development of particulate vaccines: does size matter? Methods 40 2006 1 9
37. R.J. Mumper, Z.R. Cui, and M.O. Oyewumi Nanotemplate engineering of cell specific nanoparticles J Disper Sci Technol 24 2003 569 588
38. D.R. Radu, C.Y. Lai, K. Jeftinija, E.W. Rowe, S. Jeftinija, and V.S.Y. Lin A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent J Am Chem Soc 126 2004 13216 13217
39. M. Dubois, K. Gilles, J.K. Hamilton, P.A. Rebers, and F. Smith A colorimetric method for the determination of sugars Nature 168 1951 167
40. M. Dubois, K.A. Gilles, J.K. Hamilton, P.A. Rebers, and F. Smith Colorimetric method for determination of sugars and related substances Anal Chem 28 1956 350 356
41. X.P. Wang, A. Ito, Y. Sogo, X. Li, and A. Oyane Zinc-containing apatite layers on external fixation rods promoting cell activity Acta Biomater 6 2010 962 968
42. X.P. Wang, A. Ito, Y. Sogo, X. Li, and A. Oyane Silicate-apatite composite layers on external fixation rods and in vitro evaluation using fibroblast and osteoblast J Biomed Mater Res A 92A 2010 1181 1189
43. X. Wang, A. Ito, X. Li, Y. Sogo, and A. Oyane Signal molecules - calcium phosphate coprecipitation and its biomedical application as a functional coating Biofabrication 3 2011 022001
44. K.E. La Flamme, K.C. Popat, L. Leoni, E. Markiewicz, T.J. La Tempa, and B.B. Roman Biocompatibility of nanoporous alumina membranes for immunoisolation Biomaterials 28 2007 2638 2645
45. S.P. Hudson, R.F. Padera, R. Langer, and D.S. Kohane The biocompatibility of mesoporous silicates Biomaterials 29 2008 4045 4055
46. S.R. Blumen, K. Cheng, M.E. Ramos-Nino, D.J. Taatjes, D.J. Weiss, and C.C. Landry Unique uptake of acid-prepared mesoporous spheres by lung epithelial and mesothelioma cells Am Res Cell Mol Biol 36 2007 333 342
47. T. Ukmar, A. Godec, O. Planinsek, V. Kaucic, G. Mali, and M. Gaberscek The phase (trans)formation and physical state of a model drug in mesoscopic confinement Phys Chem Chem Phys 13 2011 16046 16054
48. H. Xu, Y.B. Li, Z.J. Yang, Y. Ding, C.H. Lu, and D.X. Li Preparation of monodispersed mesoporous silica spheres with controllable particle size under an alkaline condition Int J Appl Ceram Technol 9 2012 1112 1123
49. Q.J. He, X.Z. Cui, F.M. Cui, L.M. Guo, and J.L. Shi Size-controlled synthesis of monodispersed mesoporous silica nano-spheres under a neutral condition Microporous Mesoporous Mater 117 2009 609 616
50. A. Oyane, K. Onuma, A. Ito, H.M. Kim, T. Kokubo, and T. Nakamura Formation and growth of clusters in conventional and new kinds of simulated body fluids J Biomed Mater Res A 64A 2003 339 348
51. K. Onuma, and A. Ito Cluster growth model for hydroxyapatite Chem Mater 10 1998 3346 3351
52. G. Oberdorster, E. Oberdorster, and J. Oberdorster Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles Environ Health Persp 113 2005 823 839
53. J.R. Gurr, A.S.S. Wang, C.H. Chen, and K.Y. Jan Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells Toxicology 213 2005 66 73
54. G. Oberdorster, J. Ferin, and B.E. Lehnert Correlation between particle-size, in-vivo particle persistence, and lung injury Environ Health Persp 102 1994 173 179
55. M.V.D.Z. Park, A.M. Neigh, J.P. Vermeulen, L.J.J. de la Fonteyne, H.W. Verharen, and J.J. Briede The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles Biomaterials 32 2011 9810 9817
56. 2 nanoparticles Exp Cell Res 305 2005 51 62
57. A.J.D. Pasqua, K.K. Sharma, Y.-L. Shi, B.B. Toms, W. Ouellette, and J.C. Dabrowiak Cytotoxicity of mesoporous silica nanomaterials J Inorg Biochem 102 2008 1416 1423
58. X.P. Wang, J.D. Ye, L. Chen, and H. Xiang Influence of anti-washout agents on the rheological properties and injectability of a calcium phosphate cement J Biomed Mater Res B 81B 2007 410 418
59. X.P. Wang, J.D. Ye, Y.J. Wang, X.P. Wu, and B. Bai Control of crystallinity of hydrated products in a calcium phosphate bone cement J Biomed Mater Res A 81A 2007 781 790
60. M. Epple, K. Ganesan, R. Heumann, J. Klesing, A. Kovtun, and S. Neumann Application of calcium phosphate nanoparticles in biomedicine J Mater Chem 20 2010 18 23
61. M. Vallet-Regi, and J.M. Gonzalez-Calbet Calcium phosphates as substitution of bone tissues Prog Solid State Chem 32 2004 1 31
62. R.K. Gupta, E.H. Relyveld, E.B. Lindblad, B. Bizzini, S. Benefraim, and C.K. Gupta Adjuvants a balance between toxicity and adjuvanticity Vaccine 11 1993 293 306
63. N.L. Berinstein Enhancing cancer vaccines with immunomodulators Vaccine 25 2007 B72 B88
64. W.T. Watford, M. Moriguchi, A. Morinobu, and J.J. O'Shea The biology of IL-12: coordinating innate and adaptive immune responses Cytokine Growth Factor Rev 14 2003 361 368
65. K. Fu, A.M. Klibanov, and R. Langer Protein stability in controlled-release systems Nat Biotechnol 18 2000 24 25